Outlook Therapeutics Inc. (OTLK) Decline -1.97% in Day Trading, Closes at $1.49

The price of Outlook Therapeutics Inc. (NASDAQ: OTLK) closed at $1.49 in the last session, down -1.97% from day before closing price of $1.52. In other words, the price has decreased by -$0.0300 from its previous closing price. On the day, 1008928 shares were traded. OTLK stock price reached its highest trading level at $1.5750 during the session, while it also had its lowest trading level at $1.4500.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.



We take a closer look at OTLK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 3.03 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 20 when Dagnon Terry sold 520,000 shares for $1.14 per share. The transaction valued at 590,200 led to the insider holds 653,058 shares of the business.

Evanson Jeff sold 267,000 shares of OTLK for $296,370 on Jan 20. The Chief Commercial Officer now owns 745,975 shares after completing the transaction at $1.11 per share. On Jan 19, another insider, Evanson Jeff, who serves as the Chief Commercial Officer of the company, sold 103,255 shares for $1.22 each. As a result, the insider received 125,971 and left with 1,012,975 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OTLK now has a Market Capitalization of 269.50M and an Enterprise Value of 249.01M. Its current Enterprise Value per Revenue stands at 23.71 whereas that against EBITDA is -3.74.

Stock Price History:

Over the past 52 weeks, OTLK has reached a high of $1.70, while it has fallen to a 52-week low of $0.68. The 50-Day Moving Average of the stock is 1.1234, while the 200-Day Moving Average is calculated to be 1.1250.

Shares Statistics:

According to the various share statistics, OTLK traded on average about 672.65K shares per day over the past 3-months and 1.16M shares per day over the past 10 days. A total of 256.67M shares are outstanding, with a floating share count of 109.67M. Insiders hold about 0.80% of the company’s shares, while institutions hold 10.70% stake in the company. Shares short for OTLK as of Apr 27, 2023 were 16.89M with a Short Ratio of 16.89M, compared to 16.43M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 6.58% and a Short% of Float of 9.35%.

Earnings Estimates

The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.08, while EPS last year was -$0.08. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.03 and low estimates of -$0.08.

Analysts are recommending an EPS of between -$0.18 and -$0.25 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is -$0.04, with 5 analysts recommending between $0.25 and -$0.21.

Revenue Estimates

Based on 5 analysts’ estimates, the company’s revenue will be $94.27M in the next fiscal year. The high estimate is $177.83M and the low estimate is $34.6M. The average revenue growth estimate for next year is up 1,812.20% from the average revenue estimate for this year.